ProKidney Corp.

NASDAQ:PROK

Biotechnology

Healthcare
$1.04 +0.86%

+$0.02 today

Market cap
$349.70M
Beta
1.70
P/E (TTM)
-3.3
EPS (TTM)
-$0.53
52W Low $0.54High $7.13

Volume 1.80M

Average 0.96M

Income Statement

Follow revenue through to earnings.

Revenue

$893,000.00

FY 2025 · Annual

+1075.0% YoY

Operating Income

-$165.01M

FY 2025 · Annual

Net Income

-$68.99M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00076K893K
Cost of Revenue00000
Gross Profit00076K893K
Gross Margin———100.0%100.0%
Research & Development46.26M82.07M106.71M127.67M114.12M
Selling, General & Admin8.86M70.94M44.82M56.08M51.78M
Operating Expenses55.11M153.01M151.52M183.75M165.9M
Depreciation & Amortization1.98M3.04M3.85M5.43M6.58M
EBITDA(53.12M)(143.99M)(125.59M)(158.49M)(144.62M)
EBITDA Margin———-208542.1%-16194.7%
Operating Income(55.11M)(153.01M)(151.52M)(183.68M)(165.01M)
Operating Margin———-241678.9%-18477.8%
Interest Income2K5.98M22.08M19.75M13.81M
Interest Expense0215K12K9K4K
Other Income / Expenses2K5.77M22.07M19.74M13.81M
Income Before Tax(55.11M)(147.24M)(129.45M)(163.93M)(151.2M)
Pre-Tax Margin———-215701.3%-16931.5%
Income Tax Expense38K896K6M(598K)414K
Net Income(55.15M)(108.03M)(35.47M)(61.19M)(68.99M)
Net Margin———-80507.9%-7725.2%
EPS (Basic)(1.73)(1.76)(0.57)(0.62)(0.52)
EPS (Diluted)(1.73)(1.76)(0.57)(0.62)(0.52)
Weighted Avg Shares31.89M61.54M61.71M97.92M133.94M
Weighted Avg Shares (Diluted)31.89M61.54M61.71M97.92M133.94M

PROK Earnings Waterfall · TTM

NASDAQ:PROK · Revenue to Net Income

Key Ratios

EPS$-0.55
Gross Margin-219.7%
Net Margin-8404.8%
P/E Ratio-3.2
P/S Ratio1080.9

Analysis

$889.0K of revenue converted into -$74.8M of net income for the selected period. Gross margin is -219.7% and net margin is -8404.8%, showing how much revenue survives after costs and taxes. EPS is $-0.55, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 12, 2026
424B5424B5 filingNov 12, 2026
8-KCurrent reportNov 12, 2026
EFFECTEFFECT filingNov 10, 2026
8-KCurrent reportNov 9, 2026

How much revenue does PROK generate?

ProKidney Corp. (PROK) reported $893,000.00 of revenue in fiscal 2025.

Is PROK profitable?

ProKidney Corp. (PROK) reported -$68.99M of net income, with a net margin of -7725.2%.